Administering radiation therapy to people with relapsed or refractory (resistant) multiple myeloma waiting for CAR T-cells to be manufactured was found to be safe and did not impact CAR T-cell therapy, a small study reports. The study details were shared at the virtual 2020 American Society for Radiation Oncology (ASTRO) Annual Meeting, in a presentation titled “Is Bridging Radiation (RT) Safe with B Cell Maturation Antigen–targeting Chimeric Antigenic Receptor T Cells (CART-BCMA) Therapy?” Chimeric antigen…
You must be logged in to read/download the full post.
The post Radiation Therapy Safe for Myeloma Patients Before CAR T-cell Infusion, Study Finds appeared first on BioNewsFeeds.